img

Global Antipsychotic Medicine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Antipsychotic Medicine Market Research Report 2024

According to MRAResearch’s new survey, global Antipsychotic Medicine market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antipsychotic Medicine market research.
Key companies engaged in the Antipsychotic Medicine industry include Johnson and Johnson, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Novartis, Allergan, Pfizer, GlaxoSmithKline and Otsuka Pharma, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Antipsychotic Medicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Antipsychotic Medicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Antipsychotic Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Johnson and Johnson
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Novartis
Allergan
Pfizer
GlaxoSmithKline
Otsuka Pharma
Sumitomo Dainippon
Alkermes
Vanda Pharma
Segment by Type
Oral Antipsychotics
Injectable Antipsychotics

Segment by Application


Hospital Pharmacy
Clinic Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Antipsychotic Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antipsychotic Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oral Antipsychotics
1.2.3 Injectable Antipsychotics
1.3 Market by Application
1.3.1 Global Antipsychotic Medicine Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacy
1.3.3 Clinic Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antipsychotic Medicine Market Perspective (2018-2033)
2.2 Antipsychotic Medicine Growth Trends by Region
2.2.1 Global Antipsychotic Medicine Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Antipsychotic Medicine Historic Market Size by Region (2018-2023)
2.2.3 Antipsychotic Medicine Forecasted Market Size by Region (2024-2033)
2.3 Antipsychotic Medicine Market Dynamics
2.3.1 Antipsychotic Medicine Industry Trends
2.3.2 Antipsychotic Medicine Market Drivers
2.3.3 Antipsychotic Medicine Market Challenges
2.3.4 Antipsychotic Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antipsychotic Medicine Players by Revenue
3.1.1 Global Top Antipsychotic Medicine Players by Revenue (2018-2023)
3.1.2 Global Antipsychotic Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Antipsychotic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antipsychotic Medicine Revenue
3.4 Global Antipsychotic Medicine Market Concentration Ratio
3.4.1 Global Antipsychotic Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antipsychotic Medicine Revenue in 2022
3.5 Antipsychotic Medicine Key Players Head office and Area Served
3.6 Key Players Antipsychotic Medicine Product Solution and Service
3.7 Date of Enter into Antipsychotic Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antipsychotic Medicine Breakdown Data by Type
4.1 Global Antipsychotic Medicine Historic Market Size by Type (2018-2023)
4.2 Global Antipsychotic Medicine Forecasted Market Size by Type (2024-2033)
5 Antipsychotic Medicine Breakdown Data by Application
5.1 Global Antipsychotic Medicine Historic Market Size by Application (2018-2023)
5.2 Global Antipsychotic Medicine Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Antipsychotic Medicine Market Size (2018-2033)
6.2 North America Antipsychotic Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Antipsychotic Medicine Market Size by Country (2018-2023)
6.4 North America Antipsychotic Medicine Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antipsychotic Medicine Market Size (2018-2033)
7.2 Europe Antipsychotic Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Antipsychotic Medicine Market Size by Country (2018-2023)
7.4 Europe Antipsychotic Medicine Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antipsychotic Medicine Market Size (2018-2033)
8.2 Asia-Pacific Antipsychotic Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Antipsychotic Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Antipsychotic Medicine Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antipsychotic Medicine Market Size (2018-2033)
9.2 Latin America Antipsychotic Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Antipsychotic Medicine Market Size by Country (2018-2023)
9.4 Latin America Antipsychotic Medicine Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antipsychotic Medicine Market Size (2018-2033)
10.2 Middle East & Africa Antipsychotic Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Antipsychotic Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Antipsychotic Medicine Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Detail
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Antipsychotic Medicine Introduction
11.1.4 Johnson and Johnson Revenue in Antipsychotic Medicine Business (2018-2023)
11.1.5 Johnson and Johnson Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Antipsychotic Medicine Introduction
11.2.4 Eli Lilly Revenue in Antipsychotic Medicine Business (2018-2023)
11.2.5 Eli Lilly Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Antipsychotic Medicine Introduction
11.3.4 Bristol-Myers Squibb Revenue in Antipsychotic Medicine Business (2018-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Antipsychotic Medicine Introduction
11.4.4 AstraZeneca Revenue in Antipsychotic Medicine Business (2018-2023)
11.4.5 AstraZeneca Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Antipsychotic Medicine Introduction
11.5.4 Novartis Revenue in Antipsychotic Medicine Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Allergan
11.6.1 Allergan Company Detail
11.6.2 Allergan Business Overview
11.6.3 Allergan Antipsychotic Medicine Introduction
11.6.4 Allergan Revenue in Antipsychotic Medicine Business (2018-2023)
11.6.5 Allergan Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Antipsychotic Medicine Introduction
11.7.4 Pfizer Revenue in Antipsychotic Medicine Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Antipsychotic Medicine Introduction
11.8.4 GlaxoSmithKline Revenue in Antipsychotic Medicine Business (2018-2023)
11.8.5 GlaxoSmithKline Recent Development
11.9 Otsuka Pharma
11.9.1 Otsuka Pharma Company Detail
11.9.2 Otsuka Pharma Business Overview
11.9.3 Otsuka Pharma Antipsychotic Medicine Introduction
11.9.4 Otsuka Pharma Revenue in Antipsychotic Medicine Business (2018-2023)
11.9.5 Otsuka Pharma Recent Development
11.10 Sumitomo Dainippon
11.10.1 Sumitomo Dainippon Company Detail
11.10.2 Sumitomo Dainippon Business Overview
11.10.3 Sumitomo Dainippon Antipsychotic Medicine Introduction
11.10.4 Sumitomo Dainippon Revenue in Antipsychotic Medicine Business (2018-2023)
11.10.5 Sumitomo Dainippon Recent Development
11.11 Alkermes
11.11.1 Alkermes Company Detail
11.11.2 Alkermes Business Overview
11.11.3 Alkermes Antipsychotic Medicine Introduction
11.11.4 Alkermes Revenue in Antipsychotic Medicine Business (2018-2023)
11.11.5 Alkermes Recent Development
11.12 Vanda Pharma
11.12.1 Vanda Pharma Company Detail
11.12.2 Vanda Pharma Business Overview
11.12.3 Vanda Pharma Antipsychotic Medicine Introduction
11.12.4 Vanda Pharma Revenue in Antipsychotic Medicine Business (2018-2023)
11.12.5 Vanda Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antipsychotic Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oral Antipsychotics
Table 3. Key Players of Injectable Antipsychotics
Table 4. Global Antipsychotic Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Antipsychotic Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Antipsychotic Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Antipsychotic Medicine Market Share by Region (2018-2023)
Table 8. Global Antipsychotic Medicine Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Antipsychotic Medicine Market Share by Region (2024-2033)
Table 10. Antipsychotic Medicine Market Trends
Table 11. Antipsychotic Medicine Market Drivers
Table 12. Antipsychotic Medicine Market Challenges
Table 13. Antipsychotic Medicine Market Restraints
Table 14. Global Antipsychotic Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Antipsychotic Medicine Market Share by Players (2018-2023)
Table 16. Global Top Antipsychotic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Medicine as of 2022)
Table 17. Ranking of Global Top Antipsychotic Medicine Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Antipsychotic Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antipsychotic Medicine Product Solution and Service
Table 21. Date of Enter into Antipsychotic Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antipsychotic Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Antipsychotic Medicine Revenue Market Share by Type (2018-2023)
Table 25. Global Antipsychotic Medicine Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Antipsychotic Medicine Revenue Market Share by Type (2024-2033)
Table 27. Global Antipsychotic Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Antipsychotic Medicine Revenue Market Share by Application (2018-2023)
Table 29. Global Antipsychotic Medicine Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Antipsychotic Medicine Revenue Market Share by Application (2024-2033)
Table 31. North America Antipsychotic Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Antipsychotic Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Antipsychotic Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Antipsychotic Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Antipsychotic Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Antipsychotic Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Antipsychotic Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Antipsychotic Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Antipsychotic Medicine Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Antipsychotic Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Antipsychotic Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Antipsychotic Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Antipsychotic Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Antipsychotic Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Antipsychotic Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 46. Johnson and Johnson Company Detail
Table 47. Johnson and Johnson Business Overview
Table 48. Johnson and Johnson Antipsychotic Medicine Product
Table 49. Johnson and Johnson Revenue in Antipsychotic Medicine Business (2018-2023) & (US$ Million)
Table 50. Johnson and Johnson Recent Development
Table 51. Eli Lilly Company Detail
Table 52. Eli Lilly Business Overview
Table 53. Eli Lilly Antipsychotic Medicine Product
Table 54. Eli Lilly Revenue in Antipsychotic Medicine Business (2018-2023) & (US$ Million)
Table 55. Eli Lilly Recent Development
Table 56. Bristol-Myers Squibb Company Detail
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb Antipsychotic Medicine Product
Table 59. Bristol-Myers Squibb Revenue in Antipsychotic Medicine Business (2018-2023) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. AstraZeneca Company Detail
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Antipsychotic Medicine Product
Table 64. AstraZeneca Revenue in Antipsychotic Medicine Business (2018-2023) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Novartis Company Detail
Table 67. Novartis Business Overview
Table 68. Novartis Antipsychotic Medicine Product
Table 69. Novartis Revenue in Antipsychotic Medicine Business (2018-2023) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Allergan Company Detail
Table 72. Allergan Business Overview
Table 73. Allergan Antipsychotic Medicine Product
Table 74. Allergan Revenue in Antipsychotic Medicine Business (2018-2023) & (US$ Million)
Table 75. Allergan Recent Development
Table 76. Pfizer Company Detail
Table 77. Pfizer Business Overview
Table 78. Pfizer Antipsychotic Medicine Product
Table 79. Pfizer Revenue in Antipsychotic Medicine Business (2018-2023) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. GlaxoSmithKline Company Detail
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Antipsychotic Medicine Product
Table 84. GlaxoSmithKline Revenue in Antipsychotic Medicine Business (2018-2023) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Otsuka Pharma Company Detail
Table 87. Otsuka Pharma Business Overview
Table 88. Otsuka Pharma Antipsychotic Medicine Product
Table 89. Otsuka Pharma Revenue in Antipsychotic Medicine Business (2018-2023) & (US$ Million)
Table 90. Otsuka Pharma Recent Development
Table 91. Sumitomo Dainippon Company Detail
Table 92. Sumitomo Dainippon Business Overview
Table 93. Sumitomo Dainippon Antipsychotic Medicine Product
Table 94. Sumitomo Dainippon Revenue in Antipsychotic Medicine Business (2018-2023) & (US$ Million)
Table 95. Sumitomo Dainippon Recent Development
Table 96. Alkermes Company Detail
Table 97. Alkermes Business Overview
Table 98. Alkermes Antipsychotic Medicine Product
Table 99. Alkermes Revenue in Antipsychotic Medicine Business (2018-2023) & (US$ Million)
Table 100. Alkermes Recent Development
Table 101. Vanda Pharma Company Detail
Table 102. Vanda Pharma Business Overview
Table 103. Vanda Pharma Antipsychotic Medicine Product
Table 104. Vanda Pharma Revenue in Antipsychotic Medicine Business (2018-2023) & (US$ Million)
Table 105. Vanda Pharma Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antipsychotic Medicine Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Antipsychotic Medicine Market Share by Type: 2022 VS 2033
Figure 3. Oral Antipsychotics Features
Figure 4. Injectable Antipsychotics Features
Figure 5. Global Antipsychotic Medicine Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Antipsychotic Medicine Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Clinic Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Antipsychotic Medicine Report Years Considered
Figure 11. Global Antipsychotic Medicine Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Antipsychotic Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Antipsychotic Medicine Market Share by Region: 2022 VS 2033
Figure 14. Global Antipsychotic Medicine Market Share by Players in 2022
Figure 15. Global Top Antipsychotic Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Medicine as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Antipsychotic Medicine Revenue in 2022
Figure 17. North America Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Antipsychotic Medicine Market Share by Country (2018-2033)
Figure 19. United States Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Antipsychotic Medicine Market Share by Country (2018-2033)
Figure 23. Germany Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Antipsychotic Medicine Market Share by Region (2018-2033)
Figure 31. China Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Antipsychotic Medicine Market Share by Country (2018-2033)
Figure 39. Mexico Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Antipsychotic Medicine Market Share by Country (2018-2033)
Figure 43. Turkey Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Antipsychotic Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Johnson and Johnson Revenue Growth Rate in Antipsychotic Medicine Business (2018-2023)
Figure 46. Eli Lilly Revenue Growth Rate in Antipsychotic Medicine Business (2018-2023)
Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Antipsychotic Medicine Business (2018-2023)
Figure 48. AstraZeneca Revenue Growth Rate in Antipsychotic Medicine Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Antipsychotic Medicine Business (2018-2023)
Figure 50. Allergan Revenue Growth Rate in Antipsychotic Medicine Business (2018-2023)
Figure 51. Pfizer Revenue Growth Rate in Antipsychotic Medicine Business (2018-2023)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Antipsychotic Medicine Business (2018-2023)
Figure 53. Otsuka Pharma Revenue Growth Rate in Antipsychotic Medicine Business (2018-2023)
Figure 54. Sumitomo Dainippon Revenue Growth Rate in Antipsychotic Medicine Business (2018-2023)
Figure 55. Alkermes Revenue Growth Rate in Antipsychotic Medicine Business (2018-2023)
Figure 56. Vanda Pharma Revenue Growth Rate in Antipsychotic Medicine Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed